Danish Healthtech Stock News

Why Genmab’s latest earnings and guidance update matters for investors Genmab (CPSE:GMAB) reported second quarter 2026 results with higher sales but lower net income compared with a year earlier. The company also raised full year revenue guidance, giving investors an updated view of expected performance. See our latest analysis for Genmab. Genmab’s latest earnings release and raised revenue guidance have coincided with strong recent momentum, with a 30 day share price return of 12.57% and a...

Ringkjøbing Landbobank (CPSE:RILBA) has drawn fresh attention after reporting half year 2026 results and raising its full year net profit guidance, citing stronger total income, solid credit quality and lower than budgeted losses. See our latest analysis for Ringkjøbing Landbobank. The earnings update and guidance hike appear to have supported positive momentum in Ringkjøbing Landbobank, with a 90 day share price return of 14.83% and a year to date share price return of 15.87%, while the 5...

As the European markets navigate a landscape marked by resilient economic data and geopolitical uncertainties, investors are increasingly looking towards diverse opportunities. Penny stocks, though an older term, continue to attract attention due to their potential for growth at lower price points. These smaller or newer companies can offer unique investment opportunities when backed by strong financials and solid fundamentals.

As European markets navigate a landscape marked by resilient economic data and geopolitical uncertainties, the pan-European STOXX Europe 600 Index recently experienced a slight downturn of 0.36%. Against this backdrop, dividend stocks can offer investors a source of income stability, particularly when they exhibit strong fundamentals and consistent payout histories.

Netcompany Group A/S ( CPH:NETC ) came out with its half-yearly results last week, and we wanted to see how the...

A week ago, Zealand Pharma A/S ( CPH:ZEAL ) came out with a strong set of second-quarter numbers that could potentially...

Jeudan earnings event puts focus on revenue and profit trends Jeudan (CPSE:JDAN) reported second quarter 2026 results that showed higher sales but lower net income and earnings per share compared with the same period in 2025. Investors now have fresh numbers to reassess the stock. See our latest analysis for Jeudan. Jeudan's latest earnings update comes as the stock trades at DKK204.0, with a 1-day share price return of 0.99% and a year-to-date share price gain of 3.55%. Over the same period,...

ChemoMetec (CPSE:CHEMM) drew fresh investor attention after confirming a collaboration agreement with Roche Diagnostics to link ChemoMetec’s Xcytomatic 30 cell counter to Roche’s Cedex Bio Analyzer through a dedicated hardware and software connection kit. See our latest analysis for ChemoMetec. The Roche collaboration lands at a time when ChemoMetec’s share price shows mixed signals, with a 90 day share price return of 43.79% and a year to date share price return that is down 30.97%, while...

SJF Bank (CPSE:SJF) released half year results to June 30, 2026, reporting net income of DKK 326 million compared with DKK 321.64 million a year earlier, giving investors fresh data on recent performance. See our latest analysis for SJF Bank. The half year figures come at a time when SJF Bank’s share price has gained 27.67% over three months and 14.59% year to date. The 1 year total shareholder return of 33.11% points to momentum that has been building over several years, with a 5 year total...

How NKT’s latest earnings and guidance update set the stage NKT (CPSE:NKT) reported second quarter 2026 earnings that were close to the prior year, alongside six month figures that showed similar stability in sales and net income. On the same day, the company also narrowed its 2026 revenue outlook to a range of €2.65b to €2.75b, compared with earlier guidance of €2.63b to €2.78b. This gave investors a more focused view of expected activity levels for the rest of the year. See our latest...

As the European market navigates a landscape marked by resilient economic data and geopolitical uncertainties, the STOXX Europe 600 Index recently closed slightly lower, reflecting investor caution amid these mixed signals. Despite these challenges, opportunities may exist for investors seeking undervalued stocks that could benefit from current sector shifts and regional economic resilience. In this context, identifying stocks trading below their estimated value can be particularly appealing...

A.P. Møller - Mærsk A/S ( CPH:MAERSK B ) just released its quarterly report and things are looking bullish. A.P. Møller...

Shareholders of DFDS A/S ( CPH:DFDS ) will be pleased this week, given that the stock price is up 19% to kr.155...

It's been a good week for NKT A/S ( CPH:NKT ) shareholders, because the company has just released its latest half-year...

It's been a good week for Solar A/S ( CPH:SOLAR B ) shareholders, because the company has just released its latest...

Aktieselskabet Schouw went into this report with the stock at DKK680 after a solid run over the past month, and the market is now weighing whether that optimism matches the earnings reality. The headline is clear: Q2 2026 delivered a sharp jump in profitability, with basic earnings per share at DKK14.18 and net income at DKK321m, both well ahead of Q1. In addition, management lifted full year revenue and EBITDA guidance for 2026, which puts the focus firmly on whether this improvement looks...

Tivoli stock closed at DKK632 after Q2 2026 earnings, roughly flat in recent weeks, yet the numbers behind that calm surface tell a more demanding story. The headline is valuation strain. The shares trade on a P/E of 31.6x while the wider European hospitality industry sits at 18.5x and peers at 14.2x. At the same time, trailing 12 month earnings growth is 1.9% with a net margin of 8.4%. That combination leaves investors paying a clear premium today and raises the question of how much future...

Global bond yields have pushed higher as inflation expectations adjust, which has pressured long term rates and made dependable cash flows more valuable in pricing models. When markets focus on macro swings, stocks with solid projected cash generation that also trade below fair value can get overlooked. This article highlights 3 stocks from the Undervalued Stocks Based On Cash Flows screener that stand out on this theme. The 3 stocks highlighted below are just a small sample, since the full...

FLSmidth (CPSE:FLS) stock is back in focus after the company named Petri Virrankoski as President of its Service Business Line, with a planned 2027 start. The appointment underscores attention on the service segment. See our latest analysis for FLSmidth. The leadership news comes at a time when FLSmidth’s recent momentum has been positive. The 1 month share price return is 6.38% and the 1 year total shareholder return is 27.11%. In addition, the 5 year total shareholder return of 155.07%...

Novo Nordisk (CPSE:NOVO B) has entered an AI-focused partnership with H1 to support clinical trial operations. The collaboration uses H1's proprietary AI-ready data and clinical development workflows to support drug development. The agreement is aimed at improving clinical trial design, execution and site or investigator selection through data driven insights. This kind of AI partnership in drug development sits within a wider shift toward digital and data infrastructure. It is worth...

Novozymes (CPSE:NSIS B) drew fresh attention on 12 August 2026 after Novonesis launched Optiva Triticum, a biosolution designed to give pasta producers more flexibility in wheat sourcing while preserving texture and firmness. See our latest analysis for Novozymes. At a share price of DKK424.6, Novozymes has seen a 12.27% 90 day share price return and a 49.03% three year total shareholder return. This may point to momentum that product launches like Optiva Triticum may be influencing as...

It's been a good week for Pandora A/S ( CPH:PNDORA ) shareholders, because the company has just released its latest...

Last week saw the newest first-quarter earnings release from Matas A/S ( CPH:MATAS ), an important milestone in the...

A.P. Møller - Mærsk (CPSE:MAERSK B) just released its second quarter 2026 results, reporting sales of US$15.76b and net income of US$1.26b, alongside an upgraded full year earnings outlook. See our latest analysis for A.P. Møller - Mærsk. The upgraded guidance and earnings beat have coincided with a sharp re‑rating of A.P. Møller - Mærsk, with a 40.9% year to date share price return and a 51.2% one year total shareholder return. This suggests momentum has been building as investors reassess...